[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100599841":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":25,"centralContacts":30,"locations":36,"responsibleParty":51,"collaborators":25,"id":53,"slug":54,"hasResults":55,"nctId":56,"briefTitle":57,"officialTitle":58,"acronym":25,"eligibilityCriteria":59,"healthyVolunteers":60,"sex":61,"minAge":62,"maxAge":63,"enrollmentInfo":64,"targetDuration":25,"studyType":67,"phases":68,"briefSummary":70,"conditions":71,"keywords":25,"overallStatus":74,"whyStopped":25,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":76,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":84},{"fullName":5,"class":6},"Chung Shan Medical University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"GLP-1 formula liquid drink","EXPERIMENTAL","GLP-1 formula liquid drink, 50 g\u002Fglass jar",[13],"Dietary Supplement: GLP-1 formula liquid drink",{"label":15,"type":16,"description":17,"interventionNames":18},"placebo","PLACEBO_COMPARATOR","The placebo contained the same base ingredients as the GLP-1 FORMULA but without the active GLP-1 FORMULA component.",[19],"Dietary Supplement: Placebo",[21,26],{"type":22,"name":9,"description":23,"armGroupLabels":24,"otherNames":25},"DIETARY_SUPPLEMENT","One glass jar (50 g) of the GLP-1 formula liquid drink was administered once daily, 30 minutes prior to the first meal of the day.",[9],null,{"type":22,"name":27,"description":28,"armGroupLabels":29,"otherNames":25},"Placebo","One glass jar (50 g) of the placebo liquid drink was administered once daily, 30 minutes prior to the first meal of the day.",[15],[31],{"name":32,"role":33,"phone":34,"phoneExt":25,"email":35},"Chin-Lin Hsu Professor","CONTACT","04-24730022 Ext. 12222","clhsu@csmu.edu.tw",[37],{"facility":5,"status":25,"city":38,"state":39,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"Taichung","South","402 Recruiting","Taiwan","TW",{"type":44,"coordinates":45},"Point",[46,47],120.6839,24.1469,{"lat":47,"lon":46},[50],{"name":32,"role":33,"phone":34,"phoneExt":25,"email":35},{"type":52,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR","100599841","effects-of-a-glp-1-formula-drink-on-gut-microbiota-and-glycemic-control-in-prediabetic-individuals-100599841",false,"NCT07089732","Effects of a GLP-1 Formula Drink on Gut Microbiota and Glycemic Control in Prediabetic Individuals","Evaluation of the Effects of GLP-1 Formula Liquid Drink on Gut Microbiota Modulation and Blood Glucose Regulation in Prediabetic Populations","Inclusion Criteria:\n\n* Adults aged 18 to 70 years.\n* Clinically diagnosed with prediabetes (fasting plasma glucose: 100-125 mg\u002FdL or HbA1c: 5.7-6.4%) or with a body mass index (BMI) of 25-34.9 kg\u002Fm², male or female.\n* Have not participated in similar clinical studies within the past three months.\n* Able to comprehend the informed consent form, including the study procedures, potential risks, and benefits, and able to provide written informed consent.\n\nExclusion Criteria:\n\n* Diagnosed with autoimmune diseases or cancer.\n* Diagnosed with gastrointestinal chronic diseases such as irritable bowel syndrome, inflammatory bowel disease, Crohn's disease, celiac disease, bowel control disorders, fecal incontinence, pancreatitis, peptic ulcer disease, colorectal cancer, short bowel syndrome, ulcerative colitis, lactose intolerance, or chronic diarrhea.\n* History of gastrointestinal surgery.\n* Planning pregnancy in the near future (including male partners), currently pregnant, or breastfeeding women.\n* Known allergy or hypersensitivity to probiotics or any of the study product ingredients.\n* History of major psychiatric disorders.\n* History of substance abuse or alcohol dependency.",true,"ALL","18 Years","70 Years",{"count":65,"type":66},100,"ESTIMATED","INTERVENTIONAL",[69],"NA","A clinical human dietary intervention trial was conducted to investigate the effects of GLP-1 FORMUL liquid supplementation in individuals with prediabetes or obesity, with a focus on improvements in glycemic and lipid parameters, body composition, and gut microbiota profiles.",[72,73],"Obesity","Prediabetes","NOT_YET_RECRUITING","2025-07-25",{"date":77,"type":78},"2025-07-28","ACTUAL",{"date":80,"type":66},"2025-08-08",{"date":82,"type":66},"2026-06-30",{"name":5,"class":6},1]